Abstract
ADAMs are membrane anchored glycoproteins that contain a disintegrin and metalloprotease domain. This chapter will focus on recent insights that have emerged from studies of “knockout” mice for ADAM proteases that are widely expressed or at least expressed in a variety of different cells and tissues (ADAMs 8, 9, 10, 12, 15, 17 and 19). These studies have shown that ADAM10 is important for signaling via the cell surface receptor Notch during development, while ADAM17 is critical for the development of the lung, epithelial structures and semilunar heart valves because of its role in the functional activation of ligands of the epidermal growth factor receptor. ADAM19 is essential for proper development of heart valves and the ventricular septum, although the underlying mechanism remains to be established. On the other hand, ADAMs 8, 9, 12 and 15 are dispensable for normal development and adult life in mice, at least under laboratory conditions. However, ADAM15 has a critical role in pathological neovascularization, making it a potential target for the design of inhibitors of angiogenesis. The availability of viable knockout mice for several widely expressed ADAM proteases sets the stage for a more comprehensive analysis of potential functions of these proteins in physiological and pathological processes. Furthermore, in light of the essential roles of ADAMs 10, 17 and 19 in development, it will be interesting to generate conditional knockout mice in order to evaluate the function of these proteases in adult animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, E., Mocharla, H., Yamate, T., Taguchi, Y., Manolagas, S. C., 1999, Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif Tissue Int. 64: 508–515.
Abel, S., Hundhausen, C., Mentlein, R., Schulte, A., Berkhout, T. A., Broadway, N., Hartmann, D., Sedlacek, R., Dietrich, S., Muetze, B., Schuster, B., Kallen, K. J., Saftig, P., Rose-John, S., Ludwig, A., 2004, The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like d metalloproteinase ADAM10. J Immunol. 172: 6362–6372.
Abram, C. L., Seals, D. F., Pass, I., Salinsky, D., Maurer, L., Roth, T. M., Courtneidge, S. A., 2003, The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem. 278: 16844–16851.
Al-Fakhri, N., Wilhelm, J., Hahn, M., Heidt, M., Hehrlein, F. W., Endisch, A. M., Hupp, T., Cherian, S. M., Bobryshev, Y. V., Lord, R. S., Katz, N., 2003, Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis. J Cell Biochem. 89: 808–823.
Amour, A., Knight, C. G., English, W. R., Webster, A., Slocombe, P. M., Knauper, V., Docherty, A. J., Becherer, J. D., Blobel, C. P., Murphy, G., 2002, The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett. 524: 154–158.
Artavanis-Tsakonas, S., Matsuno, K., Fortini, M. E., 1995, Notch signaling. Science. 268:225–232.
Artavanis-Tsakonas, S., Rand, M. D., Lake, R. J., 1999, Notch signaling: cell fate control and signal integration in development. Science. 284: 770–776.
Asai, M., Hattori, C., Szabo, B., Sasagawa, N., Maruyama, K., Tanuma, S., Ishiura, S., 2003, Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun. 301: 231–235.
Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., Asanuma, H., Sanada, S., Matsumura, Y., Takeda, H., Beppu, S., Tada, M., Hori, M., Higashiyama, S., 2002, Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med. 8: 35–40.
Bax, D. V., Messent, A. J., Tart, J., van Hoang, M., Kott, J., Maciewicz, R. A., Humphries, M. J., 2004, Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells. J Biol Chem. 279: 22377–22386.
Bernstein, H. G., Bukowska, A., Krell, D., Bogerts, B., Ansorge, S., Lendeckel, U., 2003, Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J Neurocytol. 32: 153–160.
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., Cerretti, D. P., 1997, A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 385: 729–733.
Blobel, C. P., Myles, D. G., Primakoff, P., White, J. M., 1990, Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J Cell Biol. 111: 69–78.
Blobel, C. P. and White, J. M., 1992, Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol. 4: 760–765.
Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P., White, J. M., 1992, A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature. 356: 248–252.
Borneman, A., Kuschel, R., Fujisawa-Sehara, A., 2000, Analysis for transcript expression of meltrin alpha in normal, regenerating, and denervated rat muscle. J Muscle Res Cell Motil. 21: 475–480.
Borrell-Pages, M., Rojo, F., Albanell, J., Baselga, J., Arribas, J., 2003, TACE is required for the activation of the EGFR by TGF-alpha in tumors. Embo J. 22: 1114–1124.
Bosse, F., Petzold, G., Greiner-Petter, R., Pippirs, U., Gillen, C., Muller, H. W., 2000, Cellular localization of the disintegrin CRII-7/rMDC15 mRNA in rat PNS and CNS and regulated expression in postnatal development and after nerve injury. Glia. 32: 313–327.
Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R. A., Israel, A., 2000, A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 5: 207–216.
Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., Black, R. A., 1998, Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem. 273: 27765–27767.
Cai, H., Kratzschmar, J., Alfandari, D., Hunnicutt, G., Blobel, C. P., 1998, Neural crest-specific and general expression of distinct metalloprotease-disintegrins in early Xenopus laevis development. Dev Biol. 204: 508–524.
Cao, Y., Kang, Q., Zhao, Z., Zolkiewska, A., 2002, Intracellular processing of metalloprotease disintegrin ADAM12. J Biol Chem. 277: 26403–26411.
Cao, Y., Kang, Q., Zolkiewska, A., 2001, Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1. Biochem J. 357: 353–361.
Cao, Y., Zhao, Z., Gruszczynska-Biegala, J., Zolkiewska, A., 2003, Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro. Mol Cell Biol. 23: 6725–6738.
Chesneau, V., Becherer, J. D., Zheng, Y., Erdjument-Bromage, H., Tempst, P., Blobel, C. P., 2003, Catalytic properties of ADAM19. J Biol Chem. 278: 22331–22340.
Cho, C., Bunch, D. O., Faure, J. E., Goulding, E. H., Eddy, E. M., Primakoff, P., Myles, D. G., 1998, Fertilization defects in sperm from mice lacking fertilin beta. Science. 281:1857–1859.
Choi, S. J., Han, J. H., Roodman, G. D., 2001, ADAM8: a novel osteoclast stimulating factor. J Bone Miner Res. 16: 814–822.
Condon, T. P., Flournoy, S., Sawyer, G. J., Baker, B. F., Kishimoto, T. K., Bennett, C. F., 2001, ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev. 11: 107–116.
Contin, C., Pitard, V., Itai, T., Nagata, S., Moreau, J. F., Dechanet-Merville, J., 2003, Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J Biol Chem. 278: 32801–32809.
Cruz, A. C., Frank, B. T., Edwards, S. T., Dazin, P. F., Peschon, J. J., Fang, K. C., 2004, Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem. 279: 5612–5620.
Eliceiri, B. P. and Cheresh, D. A., 2000, Role of alpha v integrins during angiogenesis. Cancer J. 6: S245–249.
Falls, D. L., 2003, Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 284:14–30.
Fambrough, D., Pan, D., Rubin, G. M., Goodman, C. S., 1996, The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc Natl Acad Sci U S A. 93: 13233–13238.
Fata, J. E., Kong, Y. Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., Boyle, W. J., Khokha, R., Penninger, J. M., 2000, The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 103: 41–50.
Fourie, A. M., Coles, F., Moreno, V., Karlsson, L., 2003, Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem. 278: 30469–30477.
Franzke, C. W., Tasanen, K., Borradori, L., Huotari, V., Bruckner-Tuderman, L., 2004, Shedding of Collagen XVII/BP180: STRUCTURAL MOTIFS INFLUENCE CLEAVAGE FROM CELL SURFACE. J Biol Chem. 279: 24521–24529.
Fritsche, J., Moser, M., Faust, S., Peuker, A., Buttner, R., Andreesen, R., Kreutz, M., 2000, Molecular cloning and characterization of a human metalloprotease disintegrin—a novel marker for dendritic cell differentiation. Blood. 96: 732–739.
Fritsche, J., Muller, A., Hausmann, M., Rogler, G., Andreesen, R., Kreutz, M., 2003, Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation. Immunology. 110: 450–457.
Galliano, M. F., Huet, C., Frygelius, J., Polgren, A., Wewer, U. M., Engvall, E., 2000, Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion. J Biol Chem. 275:13933–13939.
Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J., Raines, E. W., 2001, Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 276: 37993–38001.
Gilpin, B. J., Loechel, F., Mattei, M. G., Engvall, E., Albrechtsen, R., Wewer, U. M., 1998, A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem. 273: 157–166.
Goddard, D. R., Bunning, R. A., Woodroofe, M. N., 2001, Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia. 34: 267–271.
Gough, P. J., Garton, K. J., Wille, P. T., Rychlewski, M., Dempsey, P. J., Raines, E. W., 2004, A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol. 172: 3678–3685.
Greenwald, I., 1998, LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 12:1751–1762.
Grutzmann, R., Foerder, M., Alldinger, I., Staub, E., Brummendorf, T., Ropcke, S., Li, X., Kristiansen, G., Jesnowski, R., Sipos, B., Lohr, M., Luttges, J., Ockert, D., Kloppel, G., Saeger, H. D., Pilarsky, C., 2003, Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch. 443: 508–517.
Grutzmann, R., Luttges, J., Sipos, B., Ammerpohl, O., Dobrowolski, F., Alldinger, I., Kersting, S., Ockert, D., Koch, R., Kalthoff, H., Schackert, H. K., Saeger, H. D., Kloppel, G., Pilarsky, C., 2004, ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer. 90: 1053–1058.
Gschwind, A., Hart, S., Fischer, O. M., Ullrich, A., 2003, TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. Embo J. 22: 2411–2421.
Hall, R. J. and Erickson, C. A., 2003, ADAM 10: an active metalloprotease expressed during avian epithelial morphogenesis. Dev Biol. 256: 146–159.
Ham, C., Levkau, B., Raines, E. W., Herren, B., 2002, ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin. Exp Cell Res. 279: 239–247.
Harris, H. A., Murrills, R. J., Komm, B. S., 1997, Expression of meltrin-alpha mRNA is not restricted to fusagenic cells. J Cell Biochem. 67: 136–142.
Harris, R. C., Chung, E., Coffey, R. J., 2003, EGF receptor ligands. Exp Cell Res. 284: 2–13.
Hart, S., Fischer, O. M., Ullrich, A., 2004, Cannabinoids induce cancer cell proliferation via a tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64: 1943–1950.
Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lubke, T., Lena Illert, A., von Figura, K., Saftig, P., 2002, The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alphasecretase activity in fibroblasts. Hum Mol Genet. 11: 2615–2624.
Hattori, M., Osterfield, M., Flanagan, J. G., 2000, Regulated cleavage of a contact-mediated axon repellent. Science. 289: 1360–1365.
Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., van Leuven, F., De Strooper, B., 1999, Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A. 96: 11872–11877.
Herreman, A., Serneels, L., Annaert, W., Collen, D., Schoonjans, L., De Strooper, B., 2000, Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol. 2: 461–462.
Herren, B., Raines, E. W., Ross, R., 1997, Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. Faseb J. 11: 173–180.
Higuchi, Y., Yasui, A., Matsuura, K., Yamamoto, S., 2002, CD156 transgenic mice. Different responses between inflammatory types. Pathobiology. 70: 47–54.
Hinkle, C. L., Sunnarborg, S. W., Loiselle, D., Parker, C. E., Stevenson, M., Russell, W. E., Lee, D. C., 2004, Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J Biol Chem. 279: 24179–24188.
Horiuchi, K., Weskamp, G., Lum, L., Hammes, H. P., Cai, H., Brodie, T. A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K. T., Manova, K., Blobel, C. P., 2003, Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol. 23: 5614–5624.
Howard, L., Lu, X., Mitchell, S., Griffiths, S., Glynn, P., 1996, Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem J. 317: 45–50.
Howard, L., Nelson, K. K., Maciewicz, R. A., Blobel, C. P., 1999, Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. J Biol Chem. 274: 31693–31699.
Howard, L., Zheng, Y., Horrocks, M., Maciewicz, R. A., Blobel, C., 2001, Catalytic activity of ADAM28. FEBS Lett. 498: 82–86.
Huang, T. F., Holt, J. C., Lukasiewicz, H., Niewiarowski, S., 1987, Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem. 262: 16157–16163.
Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., Farese, R. V., Jr., Sheppard, D., 2000, Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol. 20: 5208–5215.
Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., Kallen, K. J., Rose-John, S., Ludwig, A., 2003, The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 102: 1186–1195.
Hussain, I., Hawkins, J., Shikotra, A., Riddell, D. R., Faller, A., Dingwall, C., 2003, Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). J Biol Chem. 278: 36264–36268.
Hynes, R. O., 2002, A reevaluation of integrins as regulators of angiogenesis. Nat Med. 8:918–921.
Iba, K., Albrechtsen, R., Gilpin, B., Frohlich, C., Loechel, F., Zolkiewska, A., Ishiguro, K., Kojima, T., Liu, W., Langford, J. K., Sanderson, R. D., Brakebusch, C., Fassler, R., Wewer, U. M., 2000, The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol. 149: 1143–1156.
Iba, K., Albrechtsen, R., Gilpin, B. J., Loechel, F., Wewer, U. M., 1999, Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol. 154: 1489–1501.
Inoue, D., Reid, M., Lum, L., Kratzschmar, J., Weskamp, G., Myung, Y. M., Baron, R., Blobel, C. P., 1998, Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells. J Biol Chem. 273: 4180–4187.
Ito, N., Nomura, S., Iwase, A., Ito, T., Kikkawa, F., Tsujimoto, M., Ishiura, S., Mizutani, S., 2004, ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun. 314: 1008–1013.
Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., Nanba, D., Higashiyama, S., Hori, M., Klagsbrun, M., Mekada, E., 2003, Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A. 100: 3221–3226.
Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S., Mekada, E., 1998, A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Embo J. 17:7260–7272.
Jackson, L. F., Qiu, T. H., Sunnarborg, S. W., Chang, A., Zhang, C., Patterson, C., Lee, D. C., 2003, Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. Embo J. 22: 2704–2716.
Jongeneel, C. V., Bouvier, J., Bairoch, A., 1989, A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242: 211–214.
Kang, Q., Cao, Y., Zolkiewska, A., 2000, Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem J. 352: 883–892.
Kang, Q., Cao, Y., Zolkiewska, A., 2001, Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells. J Biol Chem. 276: 24466–24472.
Karkkainen, I., Rybnikova, E., Pelto-Huikko, M., Huovila, A. P., 2000, Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci. 15: 547–560.
Kataoka, M., Yoshiyama, K., Matsuura, K., Hijiya, N., Higuchi, Y., Yamamoto, S., 1997, Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J Biol Chem. 272: 18209–18215.
Kawaguchi, N., Xu, X., Tajima, R., Kronqvist, P., Sundberg, C., Loechel, F., Albrechtsen, R., Wewer, U. M., 2002, ADAM 12 protease induces adipogenesis in transgenic mice. Am J Pathol. 160: 1895–1903.
Kelly, K., Hutchinson, G., Klewe-Nebenius, D., Smith, A., Bartsch, J. W., Horiuchi, K., Manova, K., Docherty, A. J., Blobel, C. P., 2004, Metalloprotease-disintegrin ADAM8: expression pattern analysis and targeted deletion in mice. Dev Dyn. (in press).
Kheradmand, F. and Werb, Z., 2002, Shedding light on sheddases: role in growth and development. Bioessays. 24: 8–12.
King, N. E., Zimmermann, N., Pope, S. M., Fulkerson, P. C., Nikolaidis, N. M., Mishra, A., Witte, D. P., Rothenberg, M. E., 2004, Expression and regulation of a disintegrin and metalloproteinase (ADAM)8 in experimental asthma. Am J Respir Cell Mol Biol. 31: 257–265.
Koike, H., Tomioka, S., Sorimachi, H., Saido, T. C., Maruyama, K., Okuyama, A., Fujisawa-Sehara, A., Ohno, S., Suzuki, K., Ishiura, S., 1999, Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J. 343: 371–375.
Kojro, E., Gimpl, G., Lammich, S., Marz, W., Fahrenholz, F., 2001, Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A. 98: 5815–5820.
Kong, Y. Y., Boyle, W. J., Penninger, J. M., 2000, Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol Today. 21: 495–502.
Kratzschmar, J., Lum, L., Blobel, C. P., 1996, Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J Biol Chem. 271: 4593–4596.
Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., Smith, G. H., Stark, K. L., Gridley, T., 2000, Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14: 1343–1352.
Kronqvist, P., Kawaguchi, N., Albrechtsen, R., Xu, X., Schroder, H. D., Moghadaszadeh, B., Nielsen, F. C., Frohlich, C., Engvall, E., Wewer, U. M., 2002, ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. Am J Pathol. 161: 1535–1540.
Kurisaki, T., Masuda, A., Osumi, N., Nabeshima, Y., Fujisawa-Sehara, A., 1998, Spatially-and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech Dev. 73: 211–215.
Kurisaki, T., Masuda, A., Sudo, K., Sakagami, J., Higashiyama, S., Matsuda, Y., Nagabukuro, A., Tsuji, A., Nabeshima, Y., Asano, M., Iwakura, Y., Sehara-Fujisawa, A., 2003, Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol Cell Biol. 23: 55–61.
Kurohara, K., Komatsu, K., Kurisaki, T., Masuda, A., Irie, N., Asano, M., Sudo, K., Nabeshima, Y., Iwakura, Y., Sehara-Fujisawa, A., 2004, Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol. 267: 14–28.
Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., Fahrenholz, F., 1999, Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A. 96: 3922–3927.
Le Pabic, H., Bonnier, D., Wewer, U. M., Coutand, A., Musso, O., Baffet, G., Clement, B., Theret, N., 2003, ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology. 37: 1056–1066.
Lemjabbar, H. and Basbaum, C., 2002, Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med. 8: 41–46.
Lieber, T., Kidd, S., Young, M. W., 2002, kuzbanian-mediated cleavage of Drosophila Notch. Genes Dev. 16: 209–221.
Loechel, F., Fox, J. W., Murphy, G., Albrechtsen, R., Wewer, U. M., 2000, ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun. 278: 511–515.
Loechel, F., Gilpin, B. J., Engvall, E., Albrechtsen, R., Wewer, U. M., 1998, Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem. 273: 16993–16997.
Lopez-Perez, E., Zhang, Y., Frank, S. J., Creemers, J., Seidah, N., Checler, F., 2001, Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem. 76: 1532–1539.
Lum, L., Reid, M. S., Blobel, C. P., 1998, Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem. 273: 26236–26247.
Mandelin, J., Li, T. F., Hukkanen, M. V., Liljestrom, M., Chen, Z. K., Santavirta, S., Kitti, U., Konttinen, Y. T., 2003, Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol. 30: 2033–2038.
Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S., Old, L. J., 1997, Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A. 94: 8093–8098.
Martin, J., Eynstone, L. V., Davies, M., Williams, J. D., Steadman, R., 2002, The role of ADAM 15 in glomerular mesangial cell migration. J Biol Chem. 277: 33683–33689.
Matthews, V., Schuster, B., Schutze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K. J., Rose-John, S., 2003, Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem. 278: 38829–38839.
Mechtersheimer, S., Gutwein, P., Agmon-Levin, N., Stoeck, A., Oleszewski, M., Riedle, S., Postina, R., Fahrenholz, F., Fogel, M., Lemmon, V., Altevogt, P., 2001, Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol. 155: 661–673.
Millichip, M. I., Dallas, D. J., Wu, E., Dale, S., McKie, N., 1998, The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun. 245: 594–598.
Mitchell, K. J., Pinson, K. I., Kelly, O. G., Brennan, J., Zupicich, J., Scherz, P., Leighton, P. A., Goodrich, L. V., Lu, X., Avery, B. J., Tate, P., Dill, K., Pangilinan, E., Wakenight, P., Tessier-Lavigne, M., Skarnes, W. C., 2001, Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet. 28: 241–249.
Mori, S., Tanaka, M., Nanba, D., Nishiwaki, E., Ishiguro, H., Higashiyama, S., Matsuura, N., 2003, PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem. 278: 46029–46034.
Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Becherer, J. D., et al.., 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385: 733–736.
Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., Ray, W. J., Kopan, R., 2000, A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 5: 197–206.
Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., Miyasaka, M., 2004, Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem. 279: 4541–4550.
Nath, D., Slocombe, P. M., Stephens, P. E., Warn, A., Hutchinson, G. R., Yamada, K. M., Docherty, A. J., Murphy, G., 1999, Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells. J Cell Sci. 112: 579–587.
Nath, D., Slocombe, P. M., Webster, A., Stephens, P. E., Docherty, A. J., Murphy, G., 2000, Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility. J Cell Sci. 113: 2319–2328.
Naus, S., Richter, M., Wildeboer, D., Schachner, M., Moss, M., Bartsch, J. W., 2004, Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J Biol Chem.
Navarro, V., Vincent, J. P., Mazella, J., 2002, Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line. Biochem Biophys Res Commun. 298: 760–764.
Nelson, K. K., Schlondorff, J., Blobel, C. P., 1999, Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. Biochem J. 343: 673–680.
Newton, R. C., Solomon, K. A., Covington, M. B., Decicco, C. P., Haley, P. J., Friedman, S. M., Vaddi, K., 2001, Biology of TACE inhibition. Ann Rheum Dis. 60: iii25–32.
Niewiarowski, S., McLane, M. A., Kloczewiak, M., Stewart, G. J., 1994, Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol. 31: 289–300.
Ohta, S., Harigai, M., Tanaka, M., Kawaguchi, Y., Sugiura, T., Takagi, K., Fukasawa, C., Hara, M., Kamatani, N., 2001, Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. J Rheumatol. 28: 1756–1763.
O’Shea, C., McKie, N., Buggy, Y., Duggan, C., Hill, A. D., McDermott, E., O’Higgins, N., Duffy, M. J., 2003, Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer. 105: 754–761.
Pan, D. and Rubin, G. M., 1997, Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell. 90: 271–280.
Pasparakis, M., Alexopoulou, L., Episkopou, V., Kollias, G., 1996, Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 184: 1397–1411.
Patel, I. R., Attur, M. G., Patel, R. N., Stuchin, S. A., Abagyan, R. A., Abramson, S. B., Amin, A. R., 1998, TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol. 160: 4570–4579.
Peiretti, F., Deprez-Beauclair, P., Bonardo, B., Aubert, H., Juhan-Vague, I., Nalbone, G., 2003, Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci. 116: 1949–1957.
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., Boyce, R. W., Nelson, N., Kozlosky, C. J., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J., Black, R. A., 1998a, An essential role for ectodomain shedding in mammalian development. Science. 282: 1281–1284.
Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B., Mohler, K. M., 1998b, TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol. 160: 943–952.
Poghosyan, Z., Robbins, S. M., Houslay, M. D., Webster, A., Murphy, G., Edwards, D. R., 2002, Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. J Biol Chem. 277: 4999–5007.
Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., Van Leuven, F., Fahrenholz, F., 2004, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest. 113: 1456–1464.
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., Ullrich, A., 1999, EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402: 884–888.
Primakoff, P., Hyatt, H., Tredick-Kline, J., 1987, Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion. J Cell Biol. 104: 141–149.
Primakoff, P. and Myles, D. G., 2000, The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16: 83–87.
Primakoff, P. and Myles, D. G., 2002, Penetration, adhesion, and fusion in mammalian sperm-egg interaction. Science. 296: 2183–2185.
Rio, C., Buxbaum, J. D., Peschon, J. J., Corfas, G., 2000, Tumor necrosis factor-alphaconverting enzyme is required for cleavage of erbB4/HER4. J Biol Chem. 275: 10379–10387.
Roghani, M., Becherer, J. D., Moss, M. L., Atherton, R. E., Erdjument-Bromage, H., Arribas, J., Blackburn, R. K., Weskamp, G., Tempst, P., Blobel, C. P., 1999, Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem. 274: 3531–3540.
Rooke, J., Pan, D., Xu, T., Rubin, G. M., 1996, KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science. 273: 1227–1231.
Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., Blobel, C. P., 2004, Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol. 164: 769–779.
Schafer, B., Gschwind, A., Ullrich, A., 2004, Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene. 23: 991–999.
Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., Bartsch, J. W., 2000, Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J Neurosci. 20: 7964–7971.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J., Lambert, M., Skelton, L., Jockusch, H., Bartsch, J. W., 2002, The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem. 277: 48210–48219.
Schlondorff, J. and Blobel, C. P., 1999, Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci. 112: 3603–3617.
Seals, D. F. and Courtneidge, S. A., 2003, The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17: 7–30.
Selkoe, D. J. and Schenk, D., 2003, Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 43: 545–584.
Setoguchi, M., Nasu, N., Yoshida, S., Higuchi, Y., Akizuki, S., Yamamoto, S., 1989, Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta. 1008: 213–222.
Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K. D., Williams, R. G., Warburton, D., 2003, TACE is required for fetal murine cardiac development and modeling. Dev Biol. 261: 371–380.
Shi, Z., Xu, W., Loechel, F., Wewer, U. M., Murphy, L. J., 2000, ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem. 275: 18574–18580.
Shintani, Y., Higashiyama, S., Ohta, M., Hirabayashi, H., Yamamoto, S., Yoshimasu, T., Matsuda, H., Matsuura, N., 2004, Overexpression of ADAM9 in Non-Small Cell Lung Cancer Correlates with Brain Metastasis. Cancer Res. 64: 4190–4196.
Shirakabe, K., Wakatsuki, S., Kurisaki, T., Fujisawa-Sehara, A., 2001, Roles of Meltrin beta /ADAM19 in the processing of neuregulin. J Biol Chem. 276: 9352–9358.
Slack, B. E., Ma, L. K., Seah, C. C., 2001, Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem J. 357: 787–794.
Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F. X., McKay, D. B., Bode, W., 1995, The metzincins—topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zincpeptidases. Protein Sci. 4: 823–840.
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., Martin, T. J., 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 20: 345–357.
Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A., Lee, D. C., 2002, Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem. 277: 12838–12845.
Suzuki, A., Kadota, N., Hara, T., Nakagami, Y., Izumi, T., Takenawa, T., Sabe, H., Endo, T., 2000, Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene. 19: 5842–5850.
Tannapfel, A., Anhalt, K., Hausermann, P., Sommerer, F., Benicke, M., Uhlmann, D., Witzigmann, H., Hauss, J., Wittekind, C., 2003, Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol. 201: 238–249.
Thathiah, A., Blobel, C. P., Carson, D. D., 2003, Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem. 278: 3386–3394.
Thodeti, C. K., Albrechtsen, R., Grauslund, M., Asmar, M., Larsson, C., Takada, Y., Mercurio, A. M., Couchman, J. R., Wewer, U. M., 2003, ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem. 278: 9576–9584.
Trochon-Joseph, V., Martel-Renoir, D., Mir, L. M., Thomaidis, A., Opolon, P., Connault, E., Li, H., Grenet, C., Fauvel-Lafeve, F., Soria, J., Legrand, C., Soria, C., Perricaudet, M., Lu, H., 2004, Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 64: 2062–2069.
Vincent, B., Paitel, E., Saftig, P., Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Lopez-Perez, E., Checler, F., 2001, The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem. 276: 37743–37746.
Wakatsuki, S., Kurisaki, T., Sehara-Fujisawa, A., 2004, Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19. J Neurochem. 89: 119–123.
Wei, P., Zhao, Y. G., Zhuang, L., Ruben, S., Sang, Q. X., 2001, Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem Biophys Res Commun. 280: 744–755.
Weskamp, G. and Blobel, C. P., 1994, A family of cellular proteins related to snake venom disintegrins. Proc Natl Acad Sci U S A. 91: 2748–2751.
Weskamp, G., Cai, H., Brodie, T. A., Higashyama, S., Manova, K., Ludwig, T., Blobel, C. P., 2002, Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol. 22: 1537–1544.
Weskamp, G., Kratzschmar, J., Reid, M. S., Blobel, C. P., 1996, MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol. 132: 717–726.
Weskamp, G., Schlondorff, J., Lum, L., Becherer, J. D., Kim, T. W., Saftig, P., Hartmann, D., Murphy, G., Blobel, C. P., 2004, Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem. 279: 4241–4249.
White, J. M., 2003, ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol. 15: 598–606.
Wolfsberg, T. G., Bazan, J. F., Blobel, C. P., Myles, D. G., Primakoff, P., White, J. M., 1993, The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc Natl Acad Sci U S A. 90: 10783–10787.
Wolfsberg, T. G., Primakoff, P., Myles, D. G., White, J. M., 1995a, ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol. 131: 275–278.
Wolfsberg, T. G., Straight, P. D., Gerena, R. L., Huovila, A. P., Primakoff, P., Myles, D. G., White, J. M., 1995b, ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol. 169: 378–383.
Yagami-Hiromasa, T., Sato, T., Kurisaki, T., Kamijo, K., Nabeshima, Y., Fujisawa-Sehara, A., 1995, A metalloprotease-disintegrin participating in myoblast fusion. Nature. 377: 652–656.
Yan, Y., Shirakabe, K., Werb, Z., 2002, The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 158: 221–226.
Yoshida, S., Setoguchi, M., Higuchi, Y., Akizuki, S., Yamamoto, S., 1990, Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol. 2: 585–591.
Yoshiyama, K., Higuchi, Y., Kataoka, M., Matsuura, K., Yamamoto, S., 1997, CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics. 41: 56–62.
Zhang, X. P., Kamata, T., Yokoyama, K., Puzon-McLaughlin, W., Takada, Y., 1998, Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem. 273: 7345–7350.
Zhang, Y., Jiang, J., Black, R. A., Baumann, G., Frank, S. J., 2000, Tumor necrosis factoralpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology. 141: 4342–4348.
Zhao, J., Chen, H., Peschon, J. J., Shi, W., Zhang, Y., Frank, S. J., Warburton, D., 2001, Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol. 232: 204–218.
Zheng, Y., Schlondorff, J., Blobel, C. P., 2002, Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem. 277: 42463–42470.
Zhou, H. M., Weskamp, G., Chesneau, V., Sahin, U., Vortkamp, A., Horiuchi, K., Chiusaroli, R., Hahn, R., Wilkes, D., Fisher, P., Baron, R., Manova, K., Basson, C. T., Hempstead, B., Blobel, C. P., 2004, Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol. 24: 96–104.
Zhou, M., Graham, R., Russell, G., Croucher, P. I., 2001, MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin. Biochem Biophys Res Commun. 280: 574–580.
Zou, J., Zhu, F., Liu, J., Wang, W., Zhang, R., Garlisi, C. G., Liu, Y. H., Wang, S., Shah, H., Wan, Y., Umland, S. P., 2004, Catalytic Activity of Human ADAM33. J Biol Chem. 279: 9818–9830.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Hoiruchi, K., Blobel, C.P. (2005). Studies from ADAM Knockout Mice. In: Hooper, N.M., Lendeckel, U. (eds) The ADAM Family of Proteases. Proteases in Biology and Disease, vol 4. Springer, Boston, MA. https://doi.org/10.1007/0-387-25151-0_2
Download citation
DOI: https://doi.org/10.1007/0-387-25151-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25149-3
Online ISBN: 978-0-387-25151-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)